Sixfold Bioscience

Developer of oligonucleotide delivery systems

placeLondon, England, United Kingdom calendar_todayFounded 2017 groups16 employees language sixfold.bio

Registered entities

Investor mix

6 investors on record; lead investors include Cantos Ventures, Y Combinator, Pi Campus, Lombardstreet Ventures.

Investor typeCountShare
Venture capital583%
Other / undisclosed117%
Coming soon